Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer

Go back to Sona's Therapy Shows Significant Preclinical Efficacy in Second Cancer
(AMEX: SNANF) Delayed: 0.26 -0.02 (7.14%)
Previous Close $0.28    52 Week High
Open $0.26    52 Week Low
Day High $0.26    P/E N/A 
Day Low $0.24    EPS
Volume 40,000